Allspring Global Investments Holdings, LLC Prometheus Biosciences, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	SELL	$103.46 - $126.29 $12,932 - $15,786	-125 Reduced 9.09%	1,250 $134,000
Q4 2022 Jan 23, 2023	SELL	$36.06 - $117.21 $1,117 - $3,633	-31 Reduced 2.2%	1,375 $151 Million
Q3 2022 Oct 26, 2022	BUY	$28.17 - $59.01 $26,282 - $55,056	933 Added 197.25%	1,406 $82,000
Q2 2022 Jul 25, 2022	SELL	$22.39 - $38.94 $122,585 - $213,196	-5,475 Reduced 92.05%	473 $13,000
Q1 2022 May 02, 2022	SELL	$30.13 - $50.0 $421 - $700	-14 Reduced 0.23%	5,948 $224,000
Q4 2021 Jan 28, 2022	BUY	$22.28 - $39.54 $132,833 - $235,737	5,962 New	5,962 $235,000

Others Institutions Holding RXDX

# of Institutions

Shares Held

29.6K

Call Options Held

Put Options Held

View Full List

About Prometheus Biosciences, Inc.

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

More about RXDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account